10007-ACT-2 FIRST IN HUMAN STUDY OF DSP-0390, AN ORAL EMOPAMIL BINDING PROTEIN (EBP) INHIBITOR, IN RECURRENT HIGH-GRADE GLIOMA (HGG): PRELIMINARY RESULTS

Arakawa, Y., Goldlust, S. A., Colman, H., Reardon, D. A., Welch, M. R., Yamaguchi, S., Butowski, N. A., Li, J., Iino, S., Song, G., Jackman, A., Xie, Y., Wagle, M.-C., Lebedinsky, C., & Narita, Y. (2023). 10007-ACT-2 FIRST IN HUMAN STUDY OF DSP-0390, AN ORAL EMOPAMIL BINDING PROTEIN (EBP) INHIBITOR, IN RECURRENT HIGH-GRADE GLIOMA (HGG): PRELIMINARY RESULTS. Neuro-Oncology Advances, 5(Supplement_5), v2–v2. https://doi.org/10.1093/noajnl/vdad141.006
Authors:
Yoshiki Arakawa
Samuel Goldlust
Howard Colman
David A. Reardon
Mary Welch
Shigeru Yamaguchi
Nicholas Butowski
Jian Li
Shuichi Iino
Gregory Song
Aimee Jackman
Yuran Xie
Marie-Claire Wagle
Claudia Lebedinsky
Yoshitaka Narita
Affiliated Authors:
Mary Welch
Columbia Affiliation:
Subjects:
Lipid Metabolism in Cancer Pathogenesis (OpenAlex Topic)
Mechanisms and Implications of Ferroptosis in Cancer (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1093/noajnl/vdad141.006
DOI:
10.1093/noajnl/vdad141.006
Journal:
Neuro-Oncology Advances
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record

Record Created: